Assignee
CISEN PHARMACEUTICAL CO LTD
CN·6 granted patents·1 pending application·2 citations·filing 2015–2021
Top patents by PatentIndex Score
7 records- 0163US9868737B2Pyridino[1,2-A]pyrimidone analogue used as MTOR/P13K inhibitorCISEN PHARMACEUTICAL CO LTD·Filed 2015·Granted Jan 16, 2018·1 cites·8 claims
- 0260US9878982B2Pyridine derivatives and anti-mycobacterial use thereofCISEN PHARMACEUTICAL CO LTD·Filed 2015·Granted Jan 30, 2018·1 cites·13 claims
- 0359US12492169B2Aminopyridine compound and application thereofCISEN PHARMACEUTICAL CO LTD·Filed 2021·Granted Dec 9, 2025·0 cites·16 claims
- 0453US12428391B2Dimethylsulfoximine derivativeCISEN PHARMACEUTICAL CO LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 0552US12583846B22H-benzopyran derivatives as CRAC inhibitorsCISEN PHARMACEUTICAL CO LTD·Filed 2020·Granted Mar 24, 2026·0 cites·16 claims
- 0651US12516070B2Fused ring derivatives and use thereof in pharmacyCISEN PHARMACEUTICAL CO LTD·Filed 2021·Granted Jan 6, 2026·0 cites·16 claims
- 0750US2024190861A1Aminopyrimidine compound as cdk2/4/6 triple inhibitorCISEN PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CISEN PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →